PRESSRELEASE ARKIV

Vi utvecklar ett nytt biologiskt läkemedel för att lindra smärtsamma symptom och öka livskvaliteten för barn och vuxna som lider av reumatism samt andra kroniska inflammatoriska sjukdomar. Lipum står nu [...]

Vd Einar Pontén intervjuas av Jonathan Furelid, IPO-Podden, inför noteringen på Nasdaq First North Growth Market. Teckning pågår fram till den 8 april 2021. [...]

Artikel i Sectoranalys: Health Care | Invest Talks ”Vår ambition är att erbjuda en bättre behandling av bland annat barn- och ledgångsreumatism, samt flera andra kroniska inflammatoriska och autoimmuna sjukdomar. [...]

Nyhet: Umeå, 23 Februari 2021. Artikel i Biostock Lipum utvecklar ett nytt biologiskt läkemedel mot kroniska inflammatoriska sjukdomar. Enligt en studie har biologiska läkemedel nästan dubbelt så stor sannolikhet för [...]

Den 29-30 september 2020 kommer vår vd Einar Pontén tillsammans med professor Olle Hernell att delta i ett digitalt möte, arrangerat av Johnson & Johnson Innovation, i samarbete med Janssen [...]

News: Umeå, 13 August 2020. Lipum participate in LSX Nordic Viritual event 1-4 September. LSX is a community of senior life science decision makers where they connect senior life science [...]

Immuneed is announceing the start of a our cooperation. Behind our project are extensive discussions and planning, which Dr. Pernilla Abrahamsson, Chief Operating Officer at Lipum sees as a cornerstone [...]

At the end of last year, we were able to announce that the cell line had been completed. Recently, another good news was brought, a significant reinforcement to the company's [...]

SwedenBIO has opened up a Q&A function on their website. Here, questions can be asked about the Swedish life science industry's role in meeting current challenges. Click here to get to [...]

– Our goal is to meet with investors interested in our next financing round,  says our CEO Einar Ponten in preparation for Bio-Europe in Hamburg, 11-13 November. […]

We are grateful for the valuable and engaged support from our Umeå Biotech Incubator coach Anne-Charlotte Aronsson. After three years with us she is now moving on and we hope [...]

Name: Pernilla Abrahamsson Education: PhD in medicine Age: 46 Family: Married, two teenagers Hobbies: We spend a lot of time in the cottage and the whole family goes [...]

Thursday 7th February we will spend with potential investors and partners together with 14 participating companies from Umeå. It's the annual Biotech Umeå Investment Day 2019. We are looking forward [...]

  According to Johnson & Johnson there are still tons of opportunity in the immunology market, even though it´s crowded. Jennifer Taubert, executive vice president and worldwide pharma chairman recently [...]

Lipum offer a new route for treatment of chronic inflammatory diseases. Meet with our CEO Einar Pontén and our CMC Project Manager Mats Reslow at BIO-Europe 2018 in Copenhagen, Nov 5-7. [...]

Lipum and some listed nordic life science companies will make company presentations in Stockholm at Nyhetsbyrån Direkt on August 29, 2018. The event is organised by Biostock and will also [...]

An international panel of life science investors have selected Lipum as one of 12 companies for the final of the live pitch competition at the Nordic Life Science Days 2018. [...]

Our project "Validation of a biological candidate drug" has been granted support from SWElife "Projects for better health" program. The competition was fierce so the green tie was used during [...]

Learn more about our novel target for treatment of chronic inflammatory diseases at Biotrinity - A Leading Biopartnering and Investment Conference in London, April 23-25, 2018 We will tell you [...]

Biotech Umeå Investment Day 2018 on February 1 at Grand Hôtel in Stockholm is a partnering event, for startups, investors and industrial partners within life science. Beside Lipum you can also [...]

Seal of Excellence Certificate by European Commission In response to Lipums application ”Novel Target for Treatment of Chronic Inflammatory Diseases” for SME Instrument 2 funding by EU’s Horizon 2020 an international [...]

Learn more about our novel target for treatment of chronic inflammatory diseases. We will attend: BIO-Europe in Berlin, Nov 6-8 Nordic-American conference in New York, Nov 13-14 RESI meeting in [...]

Lipum offer a new route for treatment of chronic inflammatory diseases. Meet with our CEO Einar Pontén at BIO-Europe 2017 in Berlin, Nov 6-8. We will tell you more on our [...]

We invite investors to join us in the development towards better treatment of chronic inflammations. Meet us and learn more at the 17th Annual Biotech in Europe Forum, Basel, Sept [...]

Lipum offer a new route for treatment of chronic inflammatory diseases such as rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). Contact us and meet with our CEO Einar Pontén at [...]

Rheumatism is an autoimmune disease that causes chronic inflammation and pain. The inflammation can break down cartilage, adjacent bones, tendons and arteries. Also eyes and other organs can be affected. About [...]

Lipum AB is the assignee of a strong patent portfolio and the rights of the patent from the inventors and the results within the BSSL research have all been transferred [...]

Biotech Umeå Investment Day 2017 at Grand Hotel in Stockholm is a partnering event, for startups, investors and industrial partners within life science. Please contact us and book a meeting in [...]

Lipum is actively seeking partners and investors for a faster development of a new biological drug towards an unique target for treatment of autoimmune inflammatory diseases. Swiss Nordic Bio in [...]